Skin cancer diagnosis has traditionally depended on spotting visible changes, with Line-Field Confocal Optical Coherence Tomography (LC-OCT) serving as a reliable tool for examining suspicious lesions. Now, researchers at Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) are pushing that boundary by pairing LC-OCT with AI-assisted image recognition to detect malignant alterations even before they become visible to the naked eye.
The team's work, as reported by Medical Xpress, suggests that AI can analyze LC-OCT images for subtle cellular patterns that precede outward symptoms. This could shift the diagnostic window earlier, allowing treatment to begin at a stage when the tumor is less developed and potentially more responsive to therapy.
While the source does not provide specific accuracy rates or clinical trial details, it emphasizes the novelty of combining established imaging with machine learning. The approach does not replace LC-OCT but augments it, offering a way to flag high-risk areas that might otherwise be missed during routine skin exams. Further validation will be needed before this becomes a standard clinical tool, but the concept marks a clear step toward proactive, rather than reactive, dermatological care.